Navigation Links
Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib
Date:12/27/2011

ROCKVILLE, Md., Dec. 27, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been approved by the Food and Drug Administration to advance to Phase Ib in its ongoing clinical trial to test its novel neuroregenerative compound, NSI-189, for the treatment of major depressive disorder (MDD). Phase Ib will test the safety and tolerability of the drug in depressed patients. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in MDD as well as other diseases and conditions, such as Alzheimer's disease and post-traumatic stress disorder (PTSD).

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )

"We are pleased to be approved to begin testing NSI-189 in patients who suffer from depression," said Karl Johe, PhD, Chief Scientific Officer and Chairman of Neuralstem's Board of Directors. "Loss of hippocampal volume is a known characteristic in depressed patients. NSI-189 stimulates neurogenesis and increases hippocampal volume in healthy adult mice, at the same time reversing behavioral symptoms in mouse depression models, so it could address depression at the source."

"It is exciting to see a new class of drugs that potentially offers a novel and different approach to this disease moving into patients," said Maurizio Fava, MD, Slater Family Professor of Psychiatry at Harvard Medical School and Executive Vice Chair of the Department of Psychiatry at Massachusetts General Hospital. Dr. Fava, one of the world's leading researchers in MDD, helped design the Neuralstem trial.

About NSI-189

Neuralstem's technology enabled the creation of neural stem cell lines from many areas of the human CNS, including the hippocampus.
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neuralstem Updates NSI-189 Major Depression Trial
2. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
10. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  BC Technical, the largest nationwide, non-OEM provider ... Inc., a leading provider of Siemens Nuclear Medicine and ... naming BC Technical as the authorized provider of service ... and BC Technical announced today that the two companies ... as the service and systems provider for MiE,s camera ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... MASON, Ohio, May 30, 2012   AssureRx Health, ... $12.5 million Series C financing. The personalized medicine ... select the right drug for individual neuropsychiatric patients, ... for its two flagship pharmacogenomic products, GeneSightRx® Psychotropic ...
... May 30, 2012 The House is scheduled to vote on ... bill is weaker than similar legislation passed by the Senate ... patients from unsafe medical devices, according to Consumers Union, the ... "The FDA is hamstrung by a weak medical device law ...
Cached Medicine Technology:AssureRx Health Raises $12.5 Million Series C Financing 2AssureRx Health Raises $12.5 Million Series C Financing 3AssureRx Health Raises $12.5 Million Series C Financing 4House Voting Today on FDA Reform Act 2
(Date:7/11/2014)... Pigments are insoluble colorants, which usually ... namely protective coating, opacity, and coloring. These are water ... color to substances such as paper, paints, plastics, and ... upon application impart color to the substance. Some examples ... and hematite. , The coloring action of pigments is ...
(Date:7/11/2014)... WASHINGTON Young adults who screened positive for a history ... by more than 50 percent after receiving mobile phone ... according to a study published online yesterday in ... Alcohol Intervention for Young Adult Emergency Department Patients: A ... U.S., more than 50,000 adults ages 18 to 24 ...
(Date:7/11/2014)... UT (PRWEB) July 11, 2014 WWTrek ... at the Kilimanjaro Kids Community in Tanzania. Opened in 2012, ... 150 chickens, and two cows. HOP Founder, Dean Cardinale, started ... for some of the orphaned children he encountered while running ... Team visited the children, who have all made astounding progress ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Fadhits.com, the ... its elegant assortment of lace holiday dresses . ... products are now offered at discounted prices, up to ... website can enjoy this special offer. , Fadhits.com ... and special occasion dresses for the global clients. All ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
Breaking Medicine News(10 mins):Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Text message medicine: Texts from the ER can reduce binge drinking 2Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
... 24 Twinlab is proud to announce the success of Team ... Mighty Montauk Triathlon. With winners in most divisions, Full Throttle Twinlab ... of a 1 mile swim, 22 mile bike ride and a ... Kalley placed second and for her first win, Allison Lind took ...
... lives of many humans, it is also a major threat ... study by the Wildlife Conservation Society (WCS). A newly ... Cancer compiles information on cancer in wildlife and suggests ... WCS authors highlight the critical need to protect both animals ...
... in Annals of Internal Medicine , , ... Bulletin Board: NVLX), an emerging healthcare consumer products company, ... in Cinnechol, one of the Company,s primary supplement products, ... lipoprotein, or LDL cholesterol, in dyslipidemic patients. LDL cholesterol ...
... Releases "Go Green" Principles to Change the Nature of ... VHA Inc., the national network of not-for-profit, community-owned ... Citizenship & Sustainability Scorecard , showing progress in ... Ratings also improved in key workplace indicators, including ...
... the American Diabetes Association, nearly 24 million people have ... unaware that they have the disease. Diabetes can affect ... heart and even the mouth. , , ... problems, including tooth decay, periodontal (gum) disease, salivary gland ...
... unconditional love , WEDNESDAY, June 24 (HealthDay News) ... away from less-than-cute babies, according to a study that ... The findings might reflect an evolutionary-based need to provide ... from Harvard-affiliated McLean Hospital in Belmont, Mass. , "Our ...
Cached Medicine News:Health News:Team Full Throttle Twinlab(R) Racing Nabs Podiums in Several Divisions at the 2009 Robert J. Aaron Memorial Mighty Montauk Triathlon 2Health News:Wildlife faces cancer threat 2Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 2Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 3Health News:Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health 4Health News:VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Network's Earth-Friendly Business Practices 2Health News:VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Network's Earth-Friendly Business Practices 3Health News:Diabetes: It's Connection to Oral Health 2Health News:Diabetes: It's Connection to Oral Health 3Health News:Women More Likely Than Men to Reject Unattractive Babies 2
Super High Density 360 degree radial rectal transducer. High resolution in the near field and lower frequencies for deeper penetration make this transducer the optimal choice when scanning the anal c...
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Medicine Products: